BioMarin Pharmaceutical
BMRN
#2072
Rank
A$13.52 B
Marketcap
A$69.99
Share price
0.28%
Change (1 day)
-23.94%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2026 (TTM): A$0.57 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are A$3.24 Billion. In 2025 the company made an earning of A$0.67 Billion a decrease over its 2024 earnings that were of A$0.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.57 B-14.97%
2025 A$0.67 B-10.94%
2024 A$0.76 B187.31%
2023 A$0.26 B26.07%
2022 A$0.21 B-298.51%
2021 -A$0.11 Billion78.04%
2020 -A$59.48 Million-55.36%
2019 -A$0.14 Billion-33.56%
2018 -A$0.21 Billion297.78%
2017 -A$50.42 Million-95.68%
2016 -A$1.17 Billion437.12%
2015 -A$0.22 Billion23.91%
2014 -A$0.18 Billion-29.25%
2013 -A$0.25 Billion49.23%
2012 -A$0.17 Billion171.11%
2011 -A$61.31 Million103.01%
2010 -A$30.2 Million-3903.54%
2009 A$0.79 M-98.31%
2008 A$46.96 M-189.7%
2007 -A$52.37 Million51.02%
2006 -A$34.68 Million-61.58%
2005 -A$90.24 Million-56.59%
2004 -A$0.21 Billion95.13%
2003 -A$0.11 Billion12.09%
2002 -A$95.03 Million73.19%
2001 -A$54.87 Million18.32%
2000 -A$46.38 Million19.65%
1999 -A$38.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
A$10.76 B 1,886.15%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-A$0.76 Billion-239.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.16 Billion-128.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-A$38.57 Million-107.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$0.26 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$0.39 B-26.47%๐Ÿ‡บ๐Ÿ‡ธ USA